Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

PIK3CA Polymorphisms Associated with Susceptibility to Hepatocellular Carcinoma.

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: A population based case-control study in China

Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer]

Low Frequency of PIK3CA Gene Mutations in Hepatocellular Carcinoma in Chinese Population.

Association Between P2rx7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in A Chinese Han Population

Cyclooxygenase-2 Gene Polymorphisms and Susceptibility to Hepatocellular Carcinoma

<i>PIK3R3</i> Missense and <i>NOTCH2</i> Synonymous Single Nucleotide Polymorphisms Are Associated with Liver Cancer

Association Between PNPLA3 Gene Polymorphisms and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Population in China:a Case-Control Study

[Association of P53 Codon 72 Polymorphism with Genetic Susceptibility to Hepatocellular Carcinoma in Chinese Population].

Association of PTEN Gene Polymorphisms with Liver Cancer Risk.

Association Of Tnf-Alpha Genetic Polymorphisms With Hepatocellular Carcinoma Susceptibility: A Case-Control Study In A Han Chinese Population

Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.

Htert Rs2736098 Genetic Variants and Susceptibility of Hepatocellular Carcinoma in the Chinese Population: a Case-Control Study

Association between polymorphism of the cyclin E1 gene and susceptibility to hepatocellular carcinoma in Chinese Han population of Hubei

Genetic Variants of P21 and P27 and Hepatocellular Cancer Risk in A Chinese Han Population: A Case-Control Study

Relevance Between Hla-Dp Gene Rs2281388 Polymorphism and Hepatocellular Carcinoma Risk

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

Common Genetic Variations Of The Cytochrome P450 1a1 Gene And Risk Of Hepatocellular Carcinoma In A Chinese Population

Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.

Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma.